Michelle Werner, Alltrna CEO
August 9, 2023 06:37 AM EDTUpdated 06:56 AM
Financing

Flag­ship start­up All­tr­na rais­es $109M for tR­NA ther­a­pies that re­store miss­ing pro­teins

Ryan Cross

Senior Science Correspondent

All­tr­na, a start­up found­ed by Flag­ship Pi­o­neer­ing, has raised $109 mil­lion in Se­ries B fi­nanc­ing to de­vel­op a new class of ge­net­ic med­i­cines based on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times